Tracking Lecanemab Response Through a Blood Biomarker (IMAGE)

Korea University College of Medicine

Tracking Lecanemab Response Through a Blood Biomarker

Caption

Researchers from Korea University investigated whether changes in plasma p-tau217 could provide an early, minimally invasive measure of biological response to lecanemab in people with early Alzheimer’s disease

Credit

Prof. Sung Hoon Kang from Korea University College of Medicine

Usage Restrictions

Cannot be reused without permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.